Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) appears in 365 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 18,626,781 | 410,721 | 2.25% | $434,749,068.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 8,432,247 | -281,273 | -3.23% | $196,808,646.00 |
| State Street Corp | 31 Dec, 2025 | 6,907,622 | 502,235 | 7.84% | $161,223,897.00 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 31 Dec, 2025 | 4,911,161 | -63,606 | -1.28% | $114,626,498.00 |
| Fundsmith LLP | 31 Dec, 2025 | 3,363,807 | 0 | 0.00% | $78,511,255.00 |
| AMERICAN CENTURY COMPANIES INC | 31 Dec, 2025 | 3,025,271 | 497,085 | 19.66% | $70,609,825.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 2,996,297 | 538,128 | 21.89% | $69,932,608.00 |
| Morgan Stanley | 31 Dec, 2025 | 2,933,399 | 1,089,775 | 59.11% | $68,465,565.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 2,900,337 | 10,017 | 0.35% | $67,704,365.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 2,650,077 | -894,753 | -25.24% | $61,852,797.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 2,199,842 | -2,382,986 | -52.00% | $51,344,312.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 1,959,086 | 951,851 | 94.50% | $45,725,068.00 |
| ROYCE & ASSOCIATES LP | 31 Dec, 2025 | 1,910,767 | -124,198 | -6.10% | $44,597,302.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 1,719,767 | 1,147,565 | 200.55% | $40,123,723.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 31 Dec, 2025 | 1,617,208 | 312,434 | 23.95% | $37,745,635.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 1,356,499 | 24,509 | 1.84% | $31,660,687.00 |
| Invesco Ltd. | 31 Dec, 2025 | 1,293,478 | 60,221 | 4.88% | $30,189,776.00 |
| Swedbank AB | 31 Dec, 2025 | 1,232,264 | 616,132 | 100.00% | $28,761,042.00 |
| Boston Partners | 31 Dec, 2025 | 1,231,372 | -59,687 | -4.62% | $28,539,969.00 |
| Northern Trust Corp | 31 Dec, 2025 | 1,211,973 | -51,915 | -4.11% | $28,287,449.00 |